🇺🇸 ABBV — AbbVie Inc.

Salud Compra
← Volver

Precio actual

293,30 USD

Máx. histórico

294,89

10 días

Caída desde máximo

-0,54%

Rango 52 semanas

190,75 – 302,93

Variación hoy

+0,68%

Cierre anterior

291,31

Rango de hoy

289,62 – 294,57

Volumen hoy

5.822.420

Peor caída histórica

-45,09%

26/01/2018 → 15/08/2019

Recuperado en 477 días

Volatilidad anualizada ⓘ

26,29%

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
50,40 (puede no estar actualizado)
Dividend yield
2,38% (puede no estar actualizado)
Precio objetivo analistas
310,65 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 4 horas
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,9200 USD · Yield: 2,36%
Fecha de pago Importe por participación
13/07/2015 0,5100 USD
13/04/2015 0,5100 USD
13/01/2015 0,4900 USD
10/10/2014 0,4200 USD
11/07/2014 0,4200 USD
11/04/2014 0,4200 USD
13/01/2014 0,4000 USD
10/10/2013 0,4000 USD
11/07/2013 0,4000 USD
11/04/2013 0,4000 USD
11/01/2013 0,4000 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/10/2019 77,79 78,02 77,19 77,75 -0,15% 1,07% 6.136.700
22/10/2019 78,05 78,66 77,75 77,87 +0,74% 1,17% 6.062.000
21/10/2019 76,88 77,85 75,85 77,30 +1,10% 2,60% 7.839.100
18/10/2019 75,24 77,17 75,21 76,46 +1,76% 2,60% 9.480.200
17/10/2019 74,99 76,18 74,65 75,14 +0,52% 2,04% 6.811.300
16/10/2019 74,38 74,98 74,34 74,75 +0,34% 0,86% 8.288.300
15/10/2019 74,20 74,98 73,80 74,50 +1,00% 1,59% 6.028.300
14/10/2019 73,65 74,17 73,39 73,76 +0,18% 1,06% 5.040.900
11/10/2019 73,97 74,34 73,57 73,63 -1,10% 1,04% 7.164.900
10/10/2019 73,22 74,63 73,20 74,45 +1,57% 1,95% 7.329.400
09/10/2019 74,07 74,62 73,25 73,30 -0,31% 1,85% 5.851.000
08/10/2019 73,88 74,75 73,42 73,53 -1,08% 1,80% 6.121.500
07/10/2019 74,72 75,27 74,08 74,33 -0,44% 1,59% 5.163.500
04/10/2019 74,22 75,06 73,95 74,66 +1,10% 1,50% 7.007.500
03/10/2019 72,06 73,94 72,04 73,85 +2,38% 2,64% 6.228.500
02/10/2019 72,89 73,00 71,57 72,13 -1,50% 1,96% 8.380.500
01/10/2019 75,89 76,03 72,94 73,23 -3,29% 4,07% 10.910.800
30/09/2019 74,95 76,44 74,95 75,72 +1,16% 1,99% 8.315.100
27/09/2019 74,21 75,14 73,92 74,85 +1,11% 1,64% 7.677.300
26/09/2019 72,95 74,46 72,62 74,03 +2,69% 2,52% 10.324.100
25/09/2019 72,88 73,24 72,02 72,09 -1,18% 1,67% 5.922.700
24/09/2019 73,83 73,83 72,17 72,95 +0,03% 2,25% 8.223.800
23/09/2019 72,33 73,78 72,05 72,93 +0,75% 2,39% 8.092.300
20/09/2019 72,00 73,00 72,00 72,39 +1,00% 1,39% 12.968.700
19/09/2019 71,40 71,91 71,21 71,67 +0,56% 0,98% 5.541.200
18/09/2019 71,68 71,82 70,81 71,27 -0,46% 1,41% 6.252.600
17/09/2019 70,51 72,09 70,36 71,60 +1,45% 2,45% 9.013.500
16/09/2019 70,37 70,96 69,72 70,58 +0,10% 1,76% 5.992.000
13/09/2019 71,15 71,51 70,48 70,51 -0,45% 1,45% 8.135.600
12/09/2019 70,76 71,17 70,19 70,83 +1,93% 1,38% 9.560.100